Fumiaki Sano
- Hematology top 10%
- Acute Myeloid Leukemia Research 6
- Chronic Myeloid Leukemia Treatments 2
-
- Retinoids in leukemia and cellular processes 2
-
- Viral-associated cancers and disorders 3
-
- Cytomegalovirus and herpesvirus research 3
- Hepatitis B Virus Studies 2
-
- Lymphoma Diagnosis and Treatment 3
-
- Streptococcal Infections and Treatments 2
- Cited by
- HematologyBiochemistryGenetics
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)British Journal of Haematology (1 paper)
In The Last Decade
Fumiaki Sano
21 papers receiving 149 citations
Peers
Comparison fields: 5 of 43
- Hematology 86
- Biochemistry 15
- Genetics 18
- Ophthalmology 13
- Molecular Biology 77
Countries citing papers authored by Fumiaki Sano
This map shows the geographic impact of Fumiaki Sano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiaki Sano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiaki Sano more than expected).
Fields of papers citing papers by Fumiaki Sano
This network shows the impact of papers produced by Fumiaki Sano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiaki Sano. The network helps show where Fumiaki Sano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fumiaki Sano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2021 | 8 | |
| 4 | 2019 | 3 | |
| 5 | 2019 | 5 | |
| 6 | 2018 | 8 | |
| 7 | 2018 | 1 | |
| 8 | 2016 | 4 | |
| 9 | 2016 | 3 | |
| 10 | 2016 | 2 | |
| 11 | 2014 | 0 | |
| 12 | 2013 | 23 | |
| 13 | 2009 | 2 | |
| 14 | Trisomy 11 acute myeloid leukemia: 5 additional cases from the Japan Adult Leukemia Study Group AML-92 and AML-95 databases. | 2000 | 2 |
| 15 | 2000 | 14 | |
| 16 | 1995 | 0 | |
| 17 | 1994 | 1 | |
| 18 | Pregnancy complicated by the May-Hegglin anomaly. | 1993 | 4 |
| 19 | [Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)]. | 1992 | 1 |
| 20 | [Thrombotic thrombocytopenic purpura associated with myasthenia gravis]. | 1991 | 0 |
About Fumiaki Sano
Fumiaki Sano is a scholar working on Hematology, Hepatology and Genetics, having authored 26 papers that have together received 153 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Viral-associated cancers and disorders (3 papers), Cytomegalovirus and herpesvirus research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Retinoids in leukemia and cellular processes (2 papers), Streptococcal Infections and Treatments (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Hematology (86 citations), Biochemistry (15 citations) and Genetics (18 citations). Fumiaki Sano has collaborated with scholars based in Japan, France and Peru. Frequent co-authors include Hiroki Yoshida, T Naoe, H Fukutani, Hitoshi Kiyoi, Kosei Matsue, R Ohno, H. Morishita, Masashi Ishida, Masatomo Takahashi and Ikuo Miura. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.